| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |